You are here

  • Home
  • Archive
  • Volume 32, Issue Suppl 2
  • 2022-RA-906-ESGO Acid ceramidase (ASAH1) expression is associated with improved progression- and overall survival in high-grade serous ovarian cancer patients

Article metrics

Article menu

Download PDFPDF

Ovarian cancer
2022-RA-906-ESGO Acid ceramidase (ASAH1) expression is associated with improved progression- and overall survival in high-grade serous ovarian cancer patients
Free

 

Online download statistics by month:

Online download statistics by month: October 2022 to October 2024

AbstractFullPdf
Oct 20221303
Nov 20221402
Dec 20224606
Jan 20231401
Feb 20231302
Mar 20231401
Apr 20231901
May 20231001
Jun 20231104
Jul 20231205
Aug 2023902
Sep 20231002
Oct 20231908
Nov 20231203
Dec 20231300
Jan 20242404
Feb 20241302
Mar 20241807
Apr 20242003
May 2024902
Jun 20241209
Jul 2024002
Aug 20241403
Sep 2024501
Oct 2024800
Total352074